A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study by Albani, Diego et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Geriatrics
Open Access Research article
A polymorphic variant of the insulin-like growth factor 1 (IGF-1) 
receptor correlates with male longevity in the Italian population: a 
genetic study and evaluation of circulating IGF-1 from the "Treviso 
Longeva (TRELONG)" study
Diego Albani*1, Sara Batelli1, Letizia Polito1, Angelica Vittori1, 
Marzia Pesaresi1, Giovanni Battista Gajo2,3, Sergio De Angeli2,3, 
Andrea Zanardo2,4, Maurizio Gallucci2,5 and Gianluigi Forloni1
Address: 1Department of Neuroscience, "Mario Negri" Institute for Pharmacological Research, via La Masa 19, I-20156 Milan, Italy, 2ARGEI, 
Interdisciplinary Geriatric Research Association, Trento Trieste Avenue 19, I-31100 Treviso, Italy, 3Trasfusional Center Treviso General Hospital, 
Piazza Ospedale 1, I-31100 Treviso, Italy, 4Clinical Chemistry Laboratory Treviso General Hospital, Piazza Ospedale, 1 I-31100 Treviso Italy and 
5Treviso General Hospital, Piazza Ospedale, 1 I-31100 Treviso Italy
Email: Diego Albani* - albani@marionegri.it; Sara Batelli - batelli@marionegri.it; Letizia Polito - polito@marionegri.it; 
Angelica Vittori - albani@marionegri.it; Marzia Pesaresi - albani@marionegri.it.it; Giovanni Battista Gajo - mgallucci@argeiricerca.it; Sergio De 
Angeli - mgallucci@argeiricerca.it; Andrea Zanardo - mgallucci@argeiricerca.it; Maurizio Gallucci - mgallucci@argeiricerca.it; 
Gianluigi Forloni - forloni@marionegri.it
* Corresponding author    
Abstract
Background:  An attenuation of the insulin-like growth factor 1 (IGF-1) signaling has been
associated with elongation of the lifespan in simple metazoan organisms and in rodents. In humans,
IGF-1 level has an age-related modulation with a lower concentration in the elderly, depending on
hormonal and genetic factors affecting the IGF-1 receptor gene (IGF-1R).
Methods: In an elderly population from North-eastern Italy (n = 668 subjects, age range 70–106
years) we investigated the IGF-1R  polymorphism G3174A (rs2229765) and the plasma
concentration of free IGF-1. Frequency distributions were compared using χ2-test "Goodness of
Fit" test, and means were compared by one-way analysis of variance (ANOVA); multiple regression
analysis was performed using JMP7 for SAS software (SAS Institute, USA). The limit of significance
for genetic and biochemical comparison was set at α = 0.05.
Results: Males showed an age-related increase in the A-allele of rs2229765 and a change in the
plasma level of IGF-1, which dropped significantly after 85 years of age (85+ group). In the male 85+
group, A/A homozygous subjects had the lowest plasma IGF-1 level. We found no clear correlation
between rs2229765 genotype and IGF-1 in the females.
Conclusion: These findings confirm the importance of the rs2229765 minor allele as a genetic
predisposing factor for longevity in Italy where a sex-specific pattern for IGF-1 attenuation with
ageing was found.
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Background
Human longevity is the result of a complex interaction
between genetics and environment (including lifestyle)
and the contribution of each factor is difficult to quantify.
Genetic components account for from 20 to 30% of
lifespan, according to twin-based population studies
[1,2].
In model organisms like Caenorhabditis elegans, Drosophila
and the mouse, several genes involved in different basic
cell pathways (stress response, DNA repair, microbial
immunity and inflammation, metabolism and calorie
restriction) have been shown to be related to longevity [3-
5]. Genes belonging to evolution-conserved pathways,
like the insulin/insulin like-growth factor 1 (IGF-1) net-
work, are of particular interest in view of their key roles in
cell physiology [6,7].
Insulin/IGF-1 signaling (IIS) triggers intracellular down-
stream transcription factors (for instance, belonging to the
FOXO family) as the final step in a signal transduction
pathway mediated by the homologous membrane recep-
tors of insulin and IGF-1 [8]. Down-regulation of IIS has
been associated with increased longevity, probably as a
consequence of the decrease in cell growth and reduction
in oxidative metabolism [9-11]. In humans the level of
circulating IGF-1 is low in the elderly, but is higher in
childhood than adulthood, probably as a consequence of
different hormonal regulation. IGF-1 expression is sensi-
tive to the growth hormone (GH) concentration and is
also influenced by sex hormones [12-14].
Genetic variations in genes belonging to the IIS pathway
have been explored in relation to longevity, dementia,
metabolic diseases and cancer [15-18]. In the Italian pop-
ulation, a synonymous polymorphism (rs2229765) on
the IGF-1 receptor gene (IGF-1R) [GenBank:NM_000875]
consisting of a G to A transition at nucleotide 3174 lead-
ing to the amino acid change Glu->Glu at position 1043
(E1043E) [GenBank:NP_000876] was evaluated and the
A-allele showed a positive association with aging and a
negative influence on circulating levels of IGF-1 [19]. The
same polymorphism has also been reported as predispos-
ing factor for ischemic stroke in China [20].
We have collected a sample of elderly people (n = 668)
from Treviso, Northeastern Italy, from 70 to 106 years old,
homogeneous for ethnicity and geographical origin, and
we have assessed their rs2229765 genotype and free IGF-1
plasma level.
Methods
Population sample recruitment
A comprehensive description of the study design has been
reported [21]. Briefly, starting from a list of about 14,000
Treviso inhabitants over 70 years of age, a population
sample was built up comprising three classes (70–79, 80–
89, 90 years and over). The list from which the sample has
been drawn comes from the population register. The final
sample size was of 668 independent subjects (311 males
and 357 females). The participants were evaluated from
the biologic, clinical and socio-economic point of view,
with a blood sample collection and a structured interview.
The study protocol presenting the inclusion criteria, col-
lecting procedure and questionnaire to be administered to
all people involved in the project, was submitted to and
approved by the Ethical Committee of the National Insti-
tute on Research and Care of the Elderly (INRCA, Italy).
This protocol includes an informed, written consent to be
obtained from the participant, or from a legally responsi-
ble relative in case of mentally impaired subjects, for clin-
ical and genetic studies.
Blood sampling and rs2229765 genotyping
Blood samples (about 30 ml) were collected by venipunc-
ture; one part was used to isolate leukocytes for gDNA
extraction, and the other was centrifuged at 2000 rpm for
10 minutes at 4°C (with sodium EDTA as anticoagulant)
to separate the plasma fraction, which was then divided
into aliquots and stored at -80°C until required. From the
final population of 668 subjects, consent for blood collec-
tion was obtained from 590 Treviso inhabitants and, in
all, 587 plasma samples were successfully prepared and
stored for further analysis.
Genomic DNA was extracted from leukocytes using a
semi-automated nucleic acid extractor (AB6100, Applera,
USA) and stored at 4°C. To assess the rs2229765 geno-
type, a gDNA aliquot (about 50 ng) was amplified by
polymerase chain reaction (PCR) using the following
primers: forward 5'-tcttctccagtgtacgttcc-3', reverse 5'-
ggaactttctctttaccacatg-3'. The resulting PCR product was
digested by MnlI (New England Biolabs Inc, UK). The
rs2229765 genotype was examined after loading the corre-
sponding enzymatic digestions on a capillary electro-
phoresis unit with standard reference markers for
instrumental lining-up (Agilent Technologies, USA).
From the available 590 gDNA samples, 510 samples gave
unambiguous digestion result and were considered for
subsequent analysis.
Plasma IGF-1 assay
Plasma IGF-1 was assayed by a specific sandwich-type
enzyme-linked immunosorbent assay (ELISA) (Diagnos-
tic System Laboratories, Inc, USA), according to the man-
ufacturer's instructions. The kit sensitivity was 10 ng/ml
and the intra-assay %CV was <10%. From the assayed 587
plasma samples, 564 gave a IGF-1 value above the kit sen-
sitivity limit and were considered for further analysis.BMC Geriatrics 2009, 9:19 http://www.biomedcentral.com/1471-2318/9/19
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Statistical analysis
Frequency distributions were compared using χ2-test
"Goodness of Fit" test (Preacher, K. J. Calculation for the
chi-square test: An interactive calculation tool for chi-
square tests of goodness of fit and independence [Compu-
ter software]. http://www.quantpsy.org) and means were
compared by one-way analysis of variance (ANOVA) fol-
lowed by Tukey's or Dunnett's post-hoc test. Analyses were
done using StatView program ver. 5.0. Multiple regression
analysis was performed using JMP7 for SAS software (SAS
Institute, USA). The limit of significance for genetic and
biochemical comparison was set at α = 0.05.
Results
Age-dependent distribution of rs2229765
The demographic and the key clinical data of the popula-
tion recruited in the TRELONG study are summarized in
[Table 1]. The sample was representative of the general eld-
erly Treviso population composition, ranging from 70 to
over 100 years, with six individuals more than 100 years.
Male-to-female ratio was 0.87. We divided the sample by
five-year intervals as shown or by comparing two groups:
the (70–85) group and the 85+ one, in an attempt to find
longevity-related traits. We chose this cut-off value as sev-
eral data suggest that after 85 years peculiar biochemical
and metabolic features can be highlighted in comparison
to the general population and also according to Italian pop-
ulation-specific survival curves [19,22,23]. This division
gave roughly two thirds of the sample under 85 and one
third over 85. Males and females were equally represented
in the (70–85) group, while in the 85+ group women were
over-represented (male-to-female ratio 0.67).
We first assessed the genotypic distribution of rs2229765
in our sample in five-year groups. No significant differ-
ence came to light (data not shown).
Then, we compared the rs2229765 genotypes in the (70–
85) and the 85+ groups [Table 2]. The genotypic distribu-
tions respected Hardy-Weinberg equilibrium in both
groups (data not shown) but there were no differences for
either genotypic or allelic frequency in the whole sample.
However, we found a sex-specific pattern as rs2229765
genotypic distribution in females under and over 85 was
different from (70–85) males. Remarkably, at allelic level
(70–85) males had a reduced A frequency (34.4%) in
comparison to 85+ males (43.7%).
Plasma IGF-1 concentration and relation between IGF-1 
level and rs2229765 genotype
We measured plasma IGF-1 concentrations in our whole
sample and plotted the results according to age but regard-
Table 1: Summary of the main demographic and clinical data of the TRELONG study. 
Age bracket (no. of people) No. of people (male:female)
70–74 (129) 61:68
75–79 (132) 72:60
80–84 (126) 64:62
85–89 (73) 29:44
90–94 (168) 74:94
95–99 (34) 10:24
100+ (6) 1:5
Total (668) 311:357
Measured variable Unit Mean ± SD
Age years 84.0 ± 8.0
Platelets N*103/mm3 235.0 ± 75.0
White cells N*103/mm3 6.43 ± 1.70
Total cholesterol mg/dl 214.0 ± 44.0
LDL cholesterol mg/dl 136.0 ± 37.0
HDL cholesterol mg/dl 56.0 ± 15.0
IgG mg/dl 1125 ± 412
Body mass index (BMI) Kg/m2 24.8 ± 4.1
Blood glucose mg/dl 105 ± 33
DCI - 2.3 ± 1.6
CCI - 5.8 ± 2.0
Smoking status Yes (278)
No (390)
DCI: disease count index; CCI: Charlson comorbidity index; SD: standard deviation.
The entire study has been detailed elsewhere [21].BMC Geriatrics 2009, 9:19 http://www.biomedcentral.com/1471-2318/9/19
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Table 2: rs2229765 genotypic and allelic frequencies according to age and sex.
Genotype count (%) Allele count (%)
Age bracket
(no. of people)
G/G G/A A/A G A χ2 p-value
(genotypic distribution)
χ2 p-value
(allelic distribution)
70–85 (288) 102 (35.4) 147 (51.1) 39 (13.5) 351 (61.0) 225 (39.0)
M (147) 59(40.0) 75 (51.0) 13 (9.0) 193 (65.6) 101 (34.4)
F (141) 43 (30.5) 72 (51.0) 26 (18.5)a 158 (56.0) 124 (44.0)ba p = 0.03 bp = 0.02
85+ (222) 70 (31.5) 110 (49.5) 42 (19.0) 250 (56.3) 194 (43.7)
M (89) 26 (29.2) 48 (53.9) 15 (16.8) 100 (56.2) 78 (43.7)c cp = 0.04
F (133) 44 (33.1) 62 (46.6) 27 (20.4)d 150 (56.4) 116 (43.6)e dp = 0.02 ep = 0.02
a: χ2 p-value for the comparison of the genotype count distribution between males 70–85 and females 70–85; b: χ2 p-value for the comparison of the 
allele count distribution between males 70–85 and females 70–85; c: χ2 p-value for the comparison of the allele count distribution between males 
70–85 and males 85+; d: χ2 p-value for the comparison of the genotype count distribution between males 70–85 and females 85+; e: χ2 p-value for 
the comparison of the allele count distribution between males 70–85 and females 85+.
M: men, F: women.
less of sex [Figure 1]. The IGF-1 concentration decreased with
age, and simple linear regression showed a significant nega-
tive correlation between age and IGF-1 level (r = -0.18, p <
0.001, sample size n = 564). To control for confounding fac-
tors, we then performed a multiple regression analysis using
IGF-1 level as dependent variable and age, sex, body mass
index (BMI), smoking, hypertension and blood glucose level
as covariates [Table 3]. The correlation was confirmed with
an even stronger significance level (p < 0.0001).
The next step was to divide the population into five-year
groups to check the longevity-related reduction in more
detail [Table 4]. There was a significant decrease starting
from 86 years in comparison to the 70–75 group, but the
91–95 group's mean IGF-1 level was not different from
the first age bracket considered. However, the 96–100
group IGF-1 plasma level was significantly lower than the
70–75 group (a 24% reduction). This difference was even
more evident in the extremely long-living subjects (40%
less than the 70–75 group) but the small sample size did
not give sufficient statistical power. This age-related IGF-1
reduction was evident by population stratification in ten-
year groups, too [Table 4].
To verify whether the age-dependent effect on IGF-1 was
influenced by sex, we compared IGF-1 levels by sex and
five-year intervals [Table 5]. We found that in males above
85 years IGF-1 decreased significantly while the mean
plasma IGF-1 was the same in females under and over this
cut-off value. This sex-specific effect was present also by
ten-year intervals [Table 5].
To check for any correlation between rs2229765 genotype
and mean IGF-1 level we stratified the sample by
rs2229765 genotype. No significant change in IGF-1 con-
centration came to light (IGF-1 mean ± standard devia-
tion: G/G 186 ± 78, n = 174; G/A 175 ± 81, n = 258; A/A
179 ± 83, n = 78; p > 0.05, one-way ANOVA). When we
did a similar analysis in the (70–85) and 85+ groups we
found a gender-specific pattern [Figure 2A]. In fact, in the
men over 85 the homozygous A class had the lowest IGF-
1 levels (119 ± 50 ng/mL, n = 15). This reduction was also
present in the heterozygous G/A group (160 ± 74 ng/mL,
n = 48) in comparison to the homozygous G/G class (185
± 74 ng/mL, n = 26). However, the above reported differ-
ence was not robust (p = 0.048 for 85+ males A/A in com-
parison to G/G group in the same age bracket) and a
chance effect cannot be excluded. We have also plotted
the individual male IGF-1 levels for the whole population
according to rs2229765 genotype and we have calculated
the linear regression using age as independent variable.
We noticed a genotype effect as the faster age-related
decrease correlated with the A/A genotype while the G/G
Age-related reduction of circulating IGF-1 Figure 1
Age-related reduction of circulating IGF-1. Scatter-
plot showing individual plasma IGF-1 levels measured by a 
dedicated ELISA kit, described in Methods. The superim-
posed line indicates the simple linear interpolation, whose 
equation and statistical significance are shown in the box on 
the graph. r: correlation coefficient.BMC Geriatrics 2009, 9:19 http://www.biomedcentral.com/1471-2318/9/19
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genotype decreased more slowly [Figure 2B]. In details,
slope, r value and significance for each genotype were the
following: (G/G) slope -1.6; r = 0.15; p = 0.15; (G/A) slope
-3.0; r = 0.27; p = 0.002; (A/A) slope -5.0; r = 0.54; p =
0.03. A similar regression analysis was performed for
females and the regression parameters were: (G/G) slope
0.13; r = 0.003.; p = 0.97; (G/A) slope -2.8; r = 0.29; p =
0.0007; (A/A) slope -1.6; r = 0.19, p = 0.09.
Discussion
Human longevity is influenced by genetic and environ-
mental factors. The present study addressed the question
whether the genetic variability due to rs2229765 polymor-
phism of the IGF-1R plays a role in human longevity. We
also sought a correlation between these genetic data and
the circulating level of IGF-1, an important molecule in
the general cell metabolism, whose reduction was found
to be beneficial for longevity in model organisms [5-7].
We collected a homogeneous sample of people from Tre-
viso (Italy), aged from 70 to 106 years (TRELONG Study)
[21]. The sample was of particular interest to highlight the
specific features of extremely long-living individuals (over
85 years) in comparison to those with a normal lifespan
(between 70 and 85 years).
The polymorphism we assessed is a synonymous amino
acidic substitution (E1043E) in the IGF-1R protein, whose
functional significance is unclear. Genetic data about the
rs2229765 did not indicate any major differences when
the population was grouped in five-year age brackets or
split in the two groups (70–85) and 85+, but there was an
increase of the A-allele in the males over 85, suggesting a
sex-specific effect on male longevity. The significance of
this increase was not robust, (p = 0.04, χ2-test) probably
because of the sample size of 85+ males. The (70–85)
male group had a lower A-allele frequency than (70–85)
females. This might be interpreted as a sex-specific effect
but might also hide a chance or recruitment bias. A con-
firmatory study in an independent male population sam-
ple from Veneto Region is required to better clarify the
Table 3: Multivariate linear model using plasma IGF-1 levels as 
dependent variable.
F p-value
Age 16.3 < 0.0001
Sex 1.1 0.27
BMI 2.4 0.11
Smoking 3.4 0.06
Hypertension 2.2 0.22
Blood glucose 0.87 0.77
rs2229765* 1.8 0.19
sex (×) age** 2.3 0.11
Total sample size: n = 564. BMI: body mass index. *calculated as A- vs. 
A+ genotype; **sex and age interaction
Table 4: Age-related IGF-1 plasma concentrations.
Age bracket No. of people IGF-1 [ng/mL] (mean ± SD)
5 years
70 – 75 103 192 ± 80
76 – 80 119 197 ± 89
81 – 85 96 184 ± 77
86 – 90 73 159 ± 68**
91 – 95 138 171 ± 76
96 – 100 29 146 ± 51**
100+ 6 117 ± 87
10 years
70 – 79 195 199 ± 88
80 – 89 177 174 ± 70 #
90 – 99 186 168 ± 75 #
>99 6 132 ± 63
** p < 0.01 vs. (70–75) group and #p <0.01 vs. (70–79) group, one-
way ANOVA followed by Dunnett's post-hoc test; SD: standard 
deviation, M: men; F: women.
Table 5: Sex-related decrease of IGF-1.
Age bracket
(no. of people)
plasma IGF-1 [ng/mL]
(mean ± SD)
Males (n = 264)
5 years 70–75 (49) 213 ± 88
76–80 (66) 204 ± 76
81–85 (50) 200 ± 81
86–90 (32) 157 ± 65 **
>90 (67) 159 ± 74 **
10 years 70–79 (99) 212 ± 83
80–89 (85) 189 ± 76
90–99 (79) 158 ± 72 §
>99 (1) 63
Females (n = 300)
5 years 70–75 (54) 175 ± 70
76–80 (53) 189 ± 104
81–85 (46) 164 ± 64
86–90 (43) 161 ± 70
>90 (104) 170 ± 73
10 years 70–79 (96) 185 ± 91
80–89 (92) 159 ± 59
90–99 (107) 173 ± 76
>99 (5) 142 ± 86
Total subjects (n = 564)
M (n = 264) 188 ± 80
F (n = 300) 172 ± 77#
**p < 0.01 vs. male (70–75) group; §p <0.01 vs. male (70–79) group; 
#p < 0.05 vs. total male subjects (n = 264), one-way ANOVA 
followed by Dunnett's post-hoc test. SD: standard deviation.BMC Geriatrics 2009, 9:19 http://www.biomedcentral.com/1471-2318/9/19
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above described limitations of the study. Our finding
about rs2229765 A-allele was partially in agreement with
a previous study in the Italian population by Bonafè et al.,
which reported an increase of the rs2229765 A-allele in
individuals over 85 years of age regardless of sex. This
aspect can be explained considering that our study design
was different, based on an elderly population sample,
while Bonafè et al. considered a wider sample ranging
from 20 to 100+ years [19]. Consequently, their increase
of the A-allele in all the people over 85 years old might
have depended on a larger difference between male A+
carriers in the two groups and does not exclude a sex-spe-
cific pattern. A gender-specific influence on longevity is a
well-known aspect that can be partially explained at
genetic level. Other polymorphisms show a gender-spe-
cific pattern in relation to longevity as well [24-26].
The second part of our study investigated plasma IGF-1
concentration, and a possible correlation between
rs2229765 and IGF-1 circulating levels. We found a linear
relationship between plasma IGF-1 and age using a simple
and a multivariate regression model, confirming that IGF-1
continues to fall through life, however long. A substantial
gender-specific effect was embedded in the general popula-
tion analysis, as men and women contributed differently to
the IGF-1 reduction: female IGF-1 in the (70–85) group
was lower than in males but it did not drop further over
time; in contrast, male IGF-1 was significantly lower in the
85+ group than the (70–85) group. Consequently, the drop
in IGF-1 over time in our population was mainly due to a
specific effect in males. This agrees with a reported sex-spe-
cific variation of IGF-1 level in model organisms, where it
is influenced by sex hormones [27-29]. Bonafé et al. also
reported a linear reduction of circulating free IGF-1 in the
Italian population [19], in accordance with our data that
magnified the effect for the elderly and found previously
unreported sex-specific difference.
We found no difference in the entire sample as regards a cor-
relation between IGF-1 plasma level and rs2229765 geno-
type. However, men showed a genotype-specific age-related
decrease of plasma IGF-1 that declined faster when the sub-
ject was homozygous for the A-allele. In females this associ-
ation was less evident, however the A-allele carriers had a
faster plasma IGF-1 decline over age than the G/G subjects.
This might suggest that in females rs2229765 impacts on cir-
culating IGF-1 level, but this is masked by other genetic or
environmental factors. This sex-specific relation was con-
firmed when we split our population at 85 years and divided
men from women, as we observed that in the 85+ males the
reduction of mean IGF-1 was unequally distributed among
the genotypic classes G/G, G/A and A/A, the last group hav-
ing the lowest IGF-1 concentration (119 ± 50 ng/mL), and
the G/G genotype the highest (185 ± 74 ng/mL) that was
comparable to the mean IGF-1 value of (70–85) men (205 ±
81 ng/mL). However, this correlation was statistically weak
(p = 0.048, Tukey's test) and a chance effect should be taken
into account. Recently, a genetic screening in Ashkenazi Jew-
ish centenarians reported gender-specific modulations of cir-
culating IGF-1 that was associated to IGF-1R  genetic
variability (including rs2229765), confirming that also this
synonymous genetic alterations in the human IGF-1R might
alter IGF signaling pathway and human longevity [30].
Conclusion
This genetic and biochemical study in the Italian popula-
tion confirmed and better detailed a genetic contribution
to longevity coming from the A-allele of the rs2229765
polymorphism in the IGF-1R gene, that correlated with
male longevity.
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Effect of sex and rs2229765 A-allele on IGF-1 circulating level Figure 2
Effect of sex and rs2229765 A-allele on IGF-1 circulat-
ing level. (A) The sample was divided into two groups, 
older and younger than 85 years of age, then each group was 
divided according to sex. The distribution of IGF-1 concen-
trations in each group was stratified according to the 
rs2229765 genotype. The vertical bars represent the mean ± 
standard deviation (SD); *: p < 0.05, Tukey's post-hoc test vs. 
M 85+ G/G group; M: men, F: women (B) Scatter plot show-
ing male rs2229765 genotype-specific linear regressions 
according to age. All males have been included. Regression 
slopes are reported next to each regression line.BMC Geriatrics 2009, 9:19 http://www.biomedcentral.com/1471-2318/9/19
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